Scalper1 News
Akorn (AKRX) is breaking out on the stock market today, boosted by a bullish initiation report. It could also be getting a lift from optimism for more buyouts in the industry: Pfizer (PFE) announced on Thursday that it’s buying injectable-drug maker Hospira (HSP) for $17 billion. Check out this video to get all the details about top-performing stock Akorn — it’s in buy range. Follow Alissa Williams on Twitter: @IBD_AWilliams. Scalper1 News
Scalper1 News